CD73 expression in lymph node metastases in patients with head and neck cancer.

about

CD73 expression and clinical significance in human metastatic melanoma.

P2860

Q55282181-3DE1C61A-9D1C-45A3-9D54-68A4AD5B236A

P2860

CD73 expression in lymph node metastases in patients with head and neck cancer.

Item

http://www.wikidata.org/entity/Q47630700

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

CD73 expression in lymph node metastases in patients with head and neck cancer.

@en

CD73 expression in lymph node metastases in patients with head and neck cancer.

@nl

type

Item

label

CD73 expression in lymph node metastases in patients with head and neck cancer.

@en

CD73 expression in lymph node metastases in patients with head and neck cancer.

@nl

prefLabel

CD73 expression in lymph node metastases in patients with head and neck cancer.

@en

CD73 expression in lymph node metastases in patients with head and neck cancer.

@nl

P1476

CD73 expression in lymph node metastases in patients with head and neck cancer.

@en

P2093

Boris Stuck

http://www.w3.org/2001/XMLSchema#string

Christian Güldner

http://www.w3.org/2001/XMLSchema#string

Christoph Netzer

http://www.w3.org/2001/XMLSchema#string

Evelyn Jahns

http://www.w3.org/2001/XMLSchema#string

Magis Mandapathil

http://www.w3.org/2001/XMLSchema#string

Marion Roessler

http://www.w3.org/2001/XMLSchema#string

Mehtap Boduc

http://www.w3.org/2001/XMLSchema#string

Ute Wallicek-Dworschak

http://www.w3.org/2001/XMLSchema#string

P2860

CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells

Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration

Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma.

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.

Immunoregulatory activity of adenosine and its role in human cancer progression.

CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.

P304

180-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00016489.2017.1378436

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28938850

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

CD73 expression in lymph node metastases in patients with head and neck cancer.

about

P2860

P2860

CD73 expression in lymph node metastases in patients with head and neck cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921